Insider Trading Alert - ACXM, RGR, MSI, CME And COF Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Nov. 20, 2013, 164 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $442.90 to $580,709,873.28.

Highlighted Stocks Traded by Insiders:

Acxiom Corporation (ACXM) - FREE Research Report

Hasselmo Ann Die who is Director at Acxiom Corporation sold 9,330 shares at $33.01 on Nov. 20, 2013. Following this transaction, the Director owned 59,217 shares meaning that the stake was reduced by 13.61% with the 9,330 share transaction.

The shares most recently traded at $33.61, up $0.60, or 1.77% since the insider transaction.

The average volume for Acxiom Corporation has been 488,400 shares per day over the past 30 days. Acxiom Corporation has a market cap of $2.5 billion and is part of the technology sector and computer software & services industry. Shares are up 88.95% year to date as of the close of trading on Wednesday.

Acxiom Corporation operates as an enterprise data, analytics, and software-as-a-service company in the United States, Europe, South America, and the Asia-Pacific. The company operates in three segments: Marketing and Data Services, IT Infrastructure Management, and Other Services. The stock currently has a dividend yield of 3.47%. The company has a P/E ratio of 49.2. Currently there are 2 analysts that rate Acxiom Corporation a buy, 1 analyst rates it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on ACXM - FREE

TheStreet Quant Ratings rates Acxiom Corporation as a buy. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures, good cash flow from operations and solid stock price performance. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Acxiom Corporation Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Sturm Ruger & Company (RGR) - FREE Research Report

Fifer Michael O who is President & CEO at Sturm Ruger & Company sold 37,000 shares at $74.61 on Nov. 20, 2013. Following this transaction, the President & CEO owned 42,292 shares meaning that the stake was reduced by 46.66% with the 37,000 share transaction.

The shares most recently traded at $77.94, up $3.33, or 4.27% since the insider transaction. Historical insider transactions for Sturm Ruger & Company go as follows:

  • 4-Week # shares sold: 25,737
  • 12-Week # shares sold: 25,737
  • 24-Week # shares sold: 105,269

The average volume for Sturm Ruger & Company has been 381,500 shares per day over the past 30 days. Sturm Ruger & Company has a market cap of $1.5 billion and is part of the industrial goods sector and aerospace/defense industry. Shares are up 65.59% year to date as of the close of trading on Wednesday.

Sturm, Ruger & Company, Inc. engages in the design, manufacture, and sale of firearms in the United States. The company offers single-shot, auto loading, bolt-action, and sporting rifles; single-action and double-action revolvers; and rim fire auto loading and center fire auto loading pistols. The stock currently has a dividend yield of 3.09%. The company has a P/E ratio of 14.3. Currently there are no analysts that rate Sturm Ruger & Company a buy, 1 analyst rates it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on RGR - FREE

TheStreet Quant Ratings rates Sturm Ruger & Company as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, expanding profit margins and solid stock price performance. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full Sturm Ruger & Company Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Motorola Solutions (MSI) - FREE Research Report

Mark Kelly S who is CVP, Strategy at Motorola Solutions sold 1,850 shares at $65.48 on Nov. 20, 2013. Following this transaction, the CVP, Strategy owned 13,636 shares meaning that the stake was reduced by 11.95% with the 1,850 share transaction.

The shares most recently traded at $65.02, down $0.46, or 0.71% since the insider transaction. Historical insider transactions for Motorola Solutions go as follows:

  • 4-Week # shares sold: 23,544
  • 12-Week # shares sold: 29,544
  • 24-Week # shares sold: 29,544

The average volume for Motorola Solutions has been 1.8 million shares per day over the past 30 days. Motorola Solutions has a market cap of $16.7 billion and is part of the technology sector and telecommunications industry. Shares are up 16.04% year to date as of the close of trading on Wednesday.

Motorola Solutions, Inc. provides mission critical communication infrastructure, devices, software, and services worldwide. It operates in two segments, Government and Enterprise. The stock currently has a dividend yield of 1.92%. The company has a P/E ratio of 16.5. Currently there are 3 analysts that rate Motorola Solutions a buy, 1 analyst rates it a sell, and 10 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on MSI - FREE

TheStreet Quant Ratings rates Motorola Solutions as a buy. The company's strengths can be seen in multiple areas, such as its impressive record of earnings per share growth, compelling growth in net income, notable return on equity, increase in stock price during the past year and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full Motorola Solutions Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

CME Group (CME) - FREE Research Report

Gepsman Martin J who is Director at CME Group sold 500 shares at $79.54 on Nov. 20, 2013. Following this transaction, the Director owned 42,570 shares meaning that the stake was reduced by 1.16% with the 500 share transaction.

Odom C C II who is Director at CME Group sold 1,532 shares at $80.03 on Nov. 20, 2013. Following this transaction, the Director owned 8,503 shares meaning that the stake was reduced by 15.27% with the 1,532 share transaction.

The shares most recently traded at $83.15, up $3.12, or 3.75% since the insider transaction. Historical insider transactions for CME Group go as follows:

  • 4-Week # shares sold: 1,200
  • 12-Week # shares bought: 350
  • 12-Week # shares sold: 4,087
  • 24-Week # shares bought: 350
  • 24-Week # shares sold: 10,739

The average volume for CME Group has been 1.6 million shares per day over the past 30 days. CME Group has a market cap of $27.2 billion and is part of the financial sector and financial services industry. Shares are up 60.13% year to date as of the close of trading on Wednesday.

CME Group Inc. operates the CME, CBOT, NYMEX COMEX, and KCBT futures exchanges worldwide. It operates CBOT exchange, a marketplace for trading agricultural and the U.S. The stock currently has a dividend yield of 2.22%. The company has a P/E ratio of 28.5. Currently there are 7 analysts that rate CME Group a buy, no analysts rate it a sell, and 7 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CME - FREE

TheStreet Quant Ratings rates CME Group as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, increase in net income, reasonable valuation levels and expanding profit margins. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full CME Group Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Capital One Financial (COF) - FREE Research Report

Fairbank Richard D who is Chairman, CEO and President at Capital One Financial sold 108,338 shares at $70.11 on Nov. 20, 2013. Following this transaction, the Chairman, CEO and President owned 2.1 million shares meaning that the stake was reduced by 4.9% with the 108,338 share transaction.

The shares most recently traded at $69.64, down $0.47, or 0.67% since the insider transaction. Historical insider transactions for Capital One Financial go as follows:

  • 4-Week # shares sold: 441,662
  • 12-Week # shares sold: 447,170
  • 24-Week # shares sold: 499,995

The average volume for Capital One Financial has been 2.9 million shares per day over the past 30 days. Capital One Financial has a market cap of $39.9 billion and is part of the financial sector and financial services industry. Shares are up 19.54% year to date as of the close of trading on Wednesday.

Capital One Financial Corporation operates as the bank holding company for the Capital One Bank (USA), National Association (COBNA); and Capital One, National Association (CONA), which provide various financial products and services in the United States. The stock currently has a dividend yield of 1.73%. The company has a P/E ratio of 9.5. Currently there are 17 analysts that rate Capital One Financial a buy, no analysts rate it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on COF - FREE

TheStreet Quant Ratings rates Capital One Financial as a buy. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures, attractive valuation levels, good cash flow from operations, increase in stock price during the past year and notable return on equity. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Capital One Financial Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Data for this article provided by Zacks Investment Research

null

More from Markets

Video: There Are Some Big Changes Coming to the PGA Championships in 2019

Video: There Are Some Big Changes Coming to the PGA Championships in 2019

Video: One-on-One With Pluralsight's CEO Following Its Successful IPO

Video: One-on-One With Pluralsight's CEO Following Its Successful IPO

CBS-Viacom Battle Comes to a Head; FDA Approves Novartis Migraine Drug --ICMYI

CBS-Viacom Battle Comes to a Head; FDA Approves Novartis Migraine Drug --ICMYI

Listen: Here's What You Need To Know About ETFs Today (Hint: They're on Fire!)

Listen: Here's What You Need To Know About ETFs Today (Hint: They're on Fire!)

Cramer and His Team Stick to Their Disciplines -- Even When It's Disappointing

Cramer and His Team Stick to Their Disciplines -- Even When It's Disappointing